Role of ¹⁸F-FDG PET/CT in the Detection of Recurrent Colorectal Carcinoma
International Journal of Pharmaceutical Quality Assurance · 30.04.2026 · 17 (04)
DOI: 10.25258/ijpqa.17.4.27 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.04.2026. Verfasst von Angel Hemrom und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Early and accurate detection of recurrent colorectal carcinoma (CRC) is crucial for timely treatment planning and improving patient outcomes.
Aim
To evaluate the role of ¹⁸F-FDG PET/CT in detecting recurrent CRC and its impact on patient management. Methodology: This retrospective observational study included 65 previously treated CRC patients who underwent ¹⁸F-FDG PET/CT for suspected recurrence, rising CEA levels, or equivocal conventional imaging. PET/CT findings were analyzed and correlated with clinical data and subsequent changes in management.
Result
PET/CT detected local recurrence in 21.5%, distant metastases in 40%, and both in 18.5% of patients, while 20% showed no evidence of disease. The most common metastatic sites were liver and lymph nodes. PET/CT findings led to a change in treatment strategy in 29.2% of cases. Conclusion: ¹⁸F-FDG PET/CT is a valuable imaging modality for detecting recurrent CRC and significantly influences patient management.
Zitieren
APA
Hemrom, A., & Mohapatra, T. K. (2026). Role of ¹⁸F-FDG PET/CT in the Detection of Recurrent Colorectal Carcinoma. International Journal of Pharmaceutical Quality Assurance, 17(04). https://doi.org/10.25258/ijpqa.17.4.27
Vancouver
Hemrom A, Mohapatra TK. Role of ¹⁸F-FDG PET/CT in the Detection of Recurrent Colorectal Carcinoma. International Journal of Pharmaceutical Quality Assurance. 2026;17(04). doi:10.25258/ijpqa.17.4.27
BibTeX
@article{Hemrom2026,
author = {Hemrom, Angel and Mohapatra, Tushar Kumar},
title = {Role of ¹⁸F-FDG PET/CT in the Detection of Recurrent Colorectal Carcinoma},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {04},
doi = {10.25258/ijpqa.17.4.27}
}
EUVIMED